Cargando…

Safety and feasibility of fasting in combination with platinum-based chemotherapy

BACKGROUND: Short-term starvation prior to chemotherapy administration protects mice against toxicity. We undertook dose-escalation of fasting prior to platinum-based chemotherapy to determine safety and feasibility in cancer patients. METHODS: 3 cohorts fasted before chemotherapy for 24, 48 and 72 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorff, Tanya B., Groshen, Susan, Garcia, Agustin, Shah, Manali, Tsao-Wei, Denice, Pham, Huyen, Cheng, Chia-Wei, Brandhorst, Sebastian, Cohen, Pinchas, Wei, Min, Longo, Valter, Quinn, David I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901417/ https://www.ncbi.nlm.nih.gov/pubmed/27282289 http://dx.doi.org/10.1186/s12885-016-2370-6

Ejemplares similares

Fasting and cancer treatment in humans: A case series report
por: Safdie, Fernando M., et al.
Publicado: (2009)

A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2014)

Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice
por: Lee, Amy S., et al.
Publicado: (2017)

Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity
por: Brandhorst, Sebastian, et al.
Publicado: (2019)

Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy
por: Di Biase, Stefano, et al.
Publicado: (2017)

Correction: Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy
por: Di Biase, Stefano, et al.
Publicado: (2017)

Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012)

Association between monocyte Fcγ subclass expression and acute coronary syndrome
por: Calverley, David C, et al.
Publicado: (2004)

Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers
por: Di Tano, Maira, et al.
Publicado: (2020)

PERIODIC FASTING MIMICKING DIET, LONGEVITY, AND DISEASE
por: Longo, Valter
Publicado: (2022)

Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
por: Yu, Steven S, et al.
Publicado: (2016)

Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis
por: Chen, Wei-Wei, et al.
Publicado: (2013)

FASTING-MIMICKING DIET REDUCES RISK FACTORS FOR AGING-RELATED DISEASES IN PRECLINICAL AND CLINICAL STUDIES
por: Brandhorst, Sebastian
Publicado: (2019)

Tivozanib in the treatment of renal cell carcinoma
por: Hepgur, Mehmet, et al.
Publicado: (2013)

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
por: Vashistha, Vishal, et al.
Publicado: (2014)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2018)

Fasting plus tyrosine kinase inhibitors in cancer
por: Caffa, Irene, et al.
Publicado: (2015)

Intermittent and Periodic Fasting, Hormones, and Cancer Prevention
por: Salvadori, Giulia, et al.
Publicado: (2021)

Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogram
por: Su, Yanping, et al.
Publicado: (2023)

Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis
por: LIU, MIAO, et al.
Publicado: (2013)

Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Zhu, Yunshu, et al.
Publicado: (2020)

IGF-I regulates the age-dependent signaling peptide humanin
por: Lee, Changhan, et al.
Publicado: (2014)

ZNF76 predicts prognosis and response to platinum chemotherapy in human ovarian cancer
por: Hua, Tian, et al.
Publicado: (2021)

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
por: Yasukawa, Maya, et al.
Publicado: (2016)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Nanocarriers containing platinum compounds for combination chemotherapy
por: Fang, Guihua, et al.
Publicado: (2022)

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
por: Hung, Hsing-Wei, et al.
Publicado: (2021)

Effect of XPC polymorphisms on the response to platinum-based chemotherapy: a meta-analysis
por: Xie, Chenyao, et al.
Publicado: (2019)

A fasting-mimicking diet and vitamin C: turning anti-aging strategies against cancer
por: Di Tano, Maira, et al.
Publicado: (2020)

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018)

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
por: Lyou, Yung, et al.
Publicado: (2021)

Cardiovascular Toxicity During Advanced Prostate Cancer Treatment: Minding the Heart
por: Dorff, Tanya, et al.
Publicado: (2023)

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer
por: Li, Min, et al.
Publicado: (2017)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
por: Afifah, Nadiya Nurul, et al.
Publicado: (2020)

Ovarian cancer resistance to PARPi and platinum-containing chemotherapy
por: Summey, Rebekah, et al.
Publicado: (2022)

An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
por: Liu, Gongyuan, et al.
Publicado: (2023)

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
por: Chen, Juan, et al.
Publicado: (2014)

Hypersensitivity Reactions to Platinum Agents and Taxanes
por: Tsao, Lulu R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uo0sdggvccu8hmm4bmji94fcri